Insmed
INSM
127 hedge funds and large institutions have $1.95B invested in Insmed in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 51 increasing their positions, 37 reducing their positions, and 17 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 37
6% more capital invested
Capital invested by funds: $1.84B → $1.95B (+$107M)
0.82% more ownership
Funds ownership: 106.79% → 107.61% (+0.82%)
0% more funds holding
Funds holding: 127 → 127 (0)
0% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 17
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
71% less call options, than puts
Call options by funds: $10M | Put options by funds: $34.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$31.1M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.27M |
| 3 |
BlackRock
New York
|
+$7.36M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$6.56M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$13.3M |
| 2 |
State Street
Boston,
Massachusetts
|
-$12.4M |
| 3 |
NC
Nexthera Capital
New York
|
-$6.99M |
| 4 |
JGC
J. Goldman & Co
New York
|
-$5.65M |
| 5 |
PC
PointState Capital
New York
|
-$5.09M |
INSM Hedge Fund Activity: Q2 2018 in Review
127 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q2 2018, worth a combined $1.95B — up 5.8% from $1.84B a quarter earlier.
Fund positioning in INSM was balanced in Q2 2018: 17 funds opened new positions, 17 closed out, 51 added to existing stakes and 37 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $31.1M. The largest seller was Victory Capital Management, exiting entirely with an estimated $13.3M sold.
- 127 institutional investors held Insmed (INSM) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $1.95B of Insmed stock for Q2 2018, up 5.8% quarter-over-quarter.
- 17 funds opened new Insmed positions in Q2 2018 and 17 closed out, a net change of 0 holders.
- The largest Insmed buyer in Q2 2018 was Janus Henderson Group, an estimated $31.1M added.
- The largest Insmed seller in Q2 2018 was Victory Capital Management, an estimated $13.3M sold.
Based on aggregated 13F filings for Q2 2018.